Should We Interrupt Oral Anticoagulation Before Percutaneous Coronary Intervention? A National Survey of UK Interventional Cardiologists - 06/12/21
Doi : 10.1016/j.hlc.2021.08.002
Annette M. Maznyczka, MRCP, PhD a, ⁎ 
, Alex Hobson, MD a, Nick Curzen, BM, PhD b, Peter A.J. Haworth, MRCP a
, Alex Hobson, MD a, Nick Curzen, BM, PhD b, Peter A.J. Haworth, MRCP a a Cardiology Department, Portsmouth Hospitals University NHS Trust, Portsmouth, UK
b Faculty of Medicine, University of Southampton & Wessex Cardiac Unit, University Hospital Southampton NHS Foundation Trust, Southampton, UK
∗Corresponding author at: Cardiology Department, Queen Alexandra Hospital, Portsmouth, UK PO63LYCardiology DepartmentQueen Alexandra HospitalPortsmouthPO63LYUK
Keywords : Percutaneous coronary intervention, Warfarin, Direct oral anticoagulant, Guidelines
El texto completo de este artículo está disponible en PDF.
Esquema
© 2021
Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 31 - N° 1
P. e5-e6 - janvier 2022 Regresar al número
Artículo precedente
- Pulmonary Valve Replacement and Redo Pulmonary Valve Replacement via Ministernotomy
- Jerome Soquet, Valentin Loobuyck, Benjamin Longere, Francois Godart, Guy Vaksmann, Mouhamed Djahoum Moussa, Francis Juthier
- Early Diagnosis of Primary Aldosteronism: The Benefits Outweigh the Costs
- Kay Weng Choy
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?